HCT 116 BRCA2 -/- 42 Cell Line
Homozygous BRCA2 knockout human cell line
Contributors
| Inventor | Institute |
|---|---|
| Carlos Caldas | Cancer Research UK Cambridge Institute |
| Cat. #: | 152628 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Digestive / Gastrointestinal cancer |
| Research Fields: | Cancer;Drug development;Genetics |
| Organism: | Human |
| Tissue: | Colon |
| Model: | Knock-Out |
| Cancer Types In Detail: | Colon Carcinoma |
| Primary citation: | Xu et al. 2014. J Pathol. 234(3):386-97. PMID: 25043256 |
| Alternate name: | HCT 116 BRCA2(-/-) clone 42; HCT 116 BRCA2(-/-) |
|---|---|
| Product description: | BRAC2 inherited mutations predispose carriers to various early onset cancers, including breast and ovarian. HCT116 BRCA2 -/- human colorectal carcinoma cell line was generated to study the role of BRCA2 in DNA repair, investigate the effects of BRCA2 mutations in a range of cancers, and identify additional functions of the BRCA2 gene. This homozygous knockout cell line shows phenotypes consistent with previous reports, including loss of Rad51 foci in the presence of double-strand breaks, chromosomal rearrangements and elevated sensitivity to the DNA-damaging agents phleomycin and Parp1 inhibitors |
| Conditional: | No |
| CRISPR: | No |
| Production details: | Targeted disruption of the human BRCA2 locus in HCT116 cells by homologous recombination. The gene targeting construct was generated by using a recombinant adeno-associated virus (rAAV) system. The deletion was confirmed by Southern Blot and Western Blot using antibodies against the C-terminus of the BRCA2 protein. This cell line was noted as clone 42 by the originating laboratory |
| Additional notes: | Clone 42 was generated at the same time as clone 46 cited in Xu et al. 2014. J Pathol. 234(3):386-97. PMID: 25043256. The originating laboratory have advised they observed no difference in culture phenotype between clone 42 and clone 46. |
| Cellosaurus ID: | CVCL_AS10 |
| Parental cell line: | HCT 116 cell line |
| Model description: | Targeted disruption of human BRCA2 by homologous recombination |
| disease: | Cancer |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | McCoy's 5a medium modified, with 10% foetal bovine serum and 2mM L-Glutamine |
| Subculture routine: | Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4×10^4 cells/cm² using 0.05% trypsin/EDTA solution. Cells are cultured at 37°C, in 95% air and 5% CO₂, and passaged every 3 to 4 days. |
| Recommended controls: | HCT116 parental line |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
Xu et al. 2014. J Pathol. 234(3):386-97. PMID: 25043256 |
|---|
Related Tools for Cell lines
| Cat. # | Tool Name | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151014 | MCF7 AREc32 Cell Line |
Key Info
MCF7 AREc32 Cell Line
|
View Tool | |||||||||||||
| 151425 | TR146 Cell Line |
Key Info
TR146 Cell Line
|
View Tool | |||||||||||||
| 151463 | Omega-E Packaging Cell Line |
Key Info
Omega-E Packaging Cell Line
|
View Tool | |||||||||||||
| 151503 | 1-7 CE1 Cell Line |
Key Info
1-7 CE1 Cell Line
|
View Tool | |||||||||||||
| 151629 | MEF Raf1 FF/FF KI Cell Line |
Key Info
MEF Raf1 FF/FF KI Cell Line
|
View Tool | |||||||||||||
